Cazzetta G - Search Results

Year	Number of Results
2005	1
2008	1
2009	1
2017	1
2018	2
2019	2
2020	1
2021	2
2023	2
2024	2
2025	2

1

Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk.

Fadini GP, Longato E, Morieri ML, Del Prato S, Avogaro A, Solini A; DARWIN-Renal Study Investigators. Fadini GP, et al. Lancet Reg Health Eur. 2024 Feb 1;38:100847. doi: 10.1016/j.lanepe.2024.100847. eCollection 2024 Mar. Lancet Reg Health Eur. 2024. PMID: 38328413 Free PMC article.

2

Long-term preservation of kidney function with SGLT-2 inhibitors versus comparator drugs in people with type 2 diabetes and chronic kidney disease.

Fadini GP, Longato E, Morieri ML, Broglio F, Aimaretti G, Russo GT, Anichini R, Ghiani M, Avogaro A, Solini A; DARWIN‐Renal Study Investigators. Fadini GP, et al. Diabetes Obes Metab. 2025 Sep;27(9):5182-5191. doi: 10.1111/dom.16569. Epub 2025 Jul 2. Diabetes Obes Metab. 2025. PMID: 40600449 Free PMC article.

3

Prevalence and risk factors of glomerular hyperfiltration in adults with type 2 diabetes: A population-based study.

Tricò D, Fadini GP, Morieri ML, Candido R, Disoteo OE, Frontoni S, Solini A; PIONEERING EXPERIENCE study group. Tricò D, et al. Diabetes Metab Res Rev. 2024 Mar;40(3):e3782. doi: 10.1002/dmrr.3782. Diabetes Metab Res Rev. 2024. PMID: 38402454

4

Effectiveness of oral semaglutide versus empagliflozin for the management of type 2 diabetes. PIONEER-2 trial emulation with real-world data.

Fadini GP, Longato E, Poletto S, Giaccari A, Ghiani M, Strazzabosco M, Trombetta M, Penno G, Avogaro A, Solini A, Consoli A; GLIMPLES study investigators and DARWIN‐Renal study investigators. Fadini GP, et al. Diabetes Obes Metab. 2025 Dec;27(12):7431-7440. doi: 10.1111/dom.70151. Epub 2025 Sep 24. Diabetes Obes Metab. 2025. PMID: 40990044 Free PMC article.

5

Transposition of cardiovascular outcome trial effects to the real-world population of patients with type 2 diabetes.

Sciannameo V, Berchialla P, Avogaro A, Fadini GP; DARWIN-T2D Network. Sciannameo V, et al. Cardiovasc Diabetol. 2021 May 10;20(1):103. doi: 10.1186/s12933-021-01300-y. Cardiovasc Diabetol. 2021. PMID: 33971880 Free PMC article.

6

Short-term effectiveness of dapagliflozin versus DPP-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study.

Morieri ML, Raz I, Consoli A, Rigato M, Lapolla A, Broglio F, Bonora E, Avogaro A, Fadini GP; DARWIN-FUP network. Morieri ML, et al. J Endocrinol Invest. 2023 Jul;46(7):1429-1439. doi: 10.1007/s40618-022-02002-2. Epub 2023 Jan 9. J Endocrinol Invest. 2023. PMID: 36624223 Free PMC article.

7

Clinical Features, Cardiovascular Risk Profile, and Therapeutic Trajectories of Patients with Type 2 Diabetes Candidate for Oral Semaglutide Therapy in the Italian Specialist Care.

Morieri ML, Candido R, Frontoni S, Disoteo O, Solini A, Fadini GP; PIONEERING EXPERIENCE study group. Morieri ML, et al. Diabetes Ther. 2023 Dec;14(12):2159-2172. doi: 10.1007/s13300-023-01490-6. Epub 2023 Oct 18. Diabetes Ther. 2023. PMID: 37848758 Free PMC article.

8

Predictors of early discontinuation of dapagliflozin versus other glucose-lowering medications: a retrospective multicenter real-world study.

Fadini GP, Li Volsi P, Devangelio E, Poli M, Cazzetta G, Felace G, Avogaro A; DARWIN-T2D Network. Fadini GP, et al. Among authors: cazzetta g. J Endocrinol Invest. 2020 Mar;43(3):329-336. doi: 10.1007/s40618-019-01110-w. Epub 2019 Sep 12. J Endocrinol Invest. 2020. PMID: 31515744

9

Effectiveness of frequency-modulated electromagnetic neural stimulation in the treatment of painful diabetic neuropathy.

Bosi E, Conti M, Vermigli C, Cazzetta G, Peretti E, Cordoni MC, Galimberti G, Scionti L. Bosi E, et al. Among authors: cazzetta g. Diabetologia. 2005 May;48(5):817-23. doi: 10.1007/s00125-005-1734-2. Epub 2005 Apr 15. Diabetologia. 2005. PMID: 15834546 Clinical Trial.

10

Frequency-modulated electromagnetic neural stimulation enhances cutaneous microvascular flow in patients with diabetic neuropathy.

Conti M, Peretti E, Cazzetta G, Galimberti G, Vermigli C, Pola R, Scionti L, Bosi E. Conti M, et al. Among authors: cazzetta g. J Diabetes Complications. 2009 Jan-Feb;23(1):46-8. doi: 10.1016/j.jdiacomp.2008.02.004. Epub 2008 Apr 10. J Diabetes Complications. 2009. PMID: 18403219 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Results by year